Williams Hart & Boundas, LLP has united with a team of leading plaintiffs' law firms to achieve a $7.25 billion settlement class action against Monsanto, resolving thousands of existing and future claims involving Roundup exposure and non-Hodgkin lymphoma (NHL). The settlement, filed on February 17, 2026, in the City of St. Louis Circuit Court, establishes a structured compensation framework for individuals diagnosed with NHL following exposure to Monsanto's glyphosate-based herbicide.
Over the past several years, juries nationwide have returned significant verdicts linking Roundup to non-Hodgkin lymphoma, while tens of thousands of claims remain pending in state and federal courts. The U.S. Supreme Court has also accepted an appeal to review the validity of these Roundup claims, adding urgency to the resolution.
"After years of pressing cases against Monsanto and in light of the fact that the U.S. Supreme Court has accepted an appeal to review the validity of these Round-Up claims, we are pleased to achieve a resolution that we believe is acceptable based on the current circumstances," said John Eddie Williams, Jr., Founding and Managing Partner of Williams Hart & Boundas, LLP.
According to the settlement, Monsanto will fund up to $7.25 billion to compensate a class that includes virtually all existing and certain future Roundup cancer claims. The agreement is designed to provide a structured and comprehensive resolution framework for individuals diagnosed with non-Hodgkin lymphoma following exposure to the herbicide. Eligible class members will have the right to opt out and pursue their claims individually if they choose.
For more information about the settlement, contact Williams Hart & Boundas, LLP at 713-940-6220. The case is filed in St. Louis city court. The settlement involves multiple law firms, including Williams Hart & Boundas, Waters Kraus Paul & Siegel, Motley Rice, Seeger Weiss, and the Holland Law Firm.
